INR ≤ 1.5 [clinicaltrials_resource:05d1f10afcca0d28c020fe3868402160]
eligibility for clinicaltrials:NCT01737450 [clinicaltrials_resource:2b8d483c8d8ab0e5cd9558ef4d542906]eligibility for clinicaltrials:NCT02376335 [clinicaltrials_resource:527061817f4b65870085c640427400dc]eligibility for clinicaltrials:NCT01266018 [clinicaltrials_resource:61072809d918542d8367afe97d8e4475]eligibility for clinicaltrials:NCT01234974 [clinicaltrials_resource:697a00d49e1c327ad89d35a75580512a]eligibility for clinicaltrials:NCT00771953 [clinicaltrials_resource:7a87e595b64d34ef61b10a20c29ccd53]eligibility for clinicaltrials:NCT01719744 [clinicaltrials_resource:8354061a4ac1f2218f4c7c47a7beaff6]eligibility for clinicaltrials:NCT01368107 [clinicaltrials_resource:ace89712ba0b7dbee5b88e2904fd5bff]eligibility for clinicaltrials:NCT02379247 [clinicaltrials_resource:ba4c5d7b519d1bd4aba15db62db423c7]eligibility for clinicaltrials:NCT02298595 [clinicaltrials_resource:cae369cb421462ca7856c8ba5e4c0737]eligibility for clinicaltrials:NCT02117817 [clinicaltrials_resource:cb03b1d6cad754dc8e7c7707979eb25e]eligibility for clinicaltrials:NCT02167711 [clinicaltrials_resource:efa19fb8a9bfcd184ddaaf49be59bf3d]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT01737450 [clinicaltrials_resource:2b8d483c8d8ab0e5cd9558ef4d542906]eligibility for clinicaltrials:NCT00408694 [clinicaltrials_resource:2e196d405997dd4f84c6c6499182d6b2]eligibility for clinicaltrials:NCT02376335 [clinicaltrials_resource:527061817f4b65870085c640427400dc]eligibility for clinicaltrials:NCT01266018 [clinicaltrials_resource:61072809d918542d8367afe97d8e4475]eligibility for clinicaltrials:NCT01159301 [clinicaltrials_resource:655c301682c937d4832cd67c710c7054]eligibility for clinicaltrials:NCT01234974 [clinicaltrials_resource:697a00d49e1c327ad89d35a75580512a]eligibility for clinicaltrials:NCT00771953 [clinicaltrials_resource:7a87e595b64d34ef61b10a20c29ccd53]eligibility for clinicaltrials:NCT00245102 [clinicaltrials_resource:7f0cd7e6082e671f02f38c42311e9da6]eligibility for clinicaltrials:NCT01719744 [clinicaltrials_resource:8354061a4ac1f2218f4c7c47a7beaff6]eligibility for clinicaltrials:NCT01368107 [clinicaltrials_resource:ace89712ba0b7dbee5b88e2904fd5bff]eligibility for clinicaltrials:NCT02379247 [clinicaltrials_resource:ba4c5d7b519d1bd4aba15db62db423c7]eligibility for clinicaltrials:NCT00079430 [clinicaltrials_resource:c9d408a14051340c8958175879caa337]eligibility for clinicaltrials:NCT02298595 [clinicaltrials_resource:cae369cb421462ca7856c8ba5e4c0737]eligibility for clinicaltrials:NCT02117817 [clinicaltrials_resource:cb03b1d6cad754dc8e7c7707979eb25e]eligibility for clinicaltrials:NCT02167711 [clinicaltrials_resource:efa19fb8a9bfcd184ddaaf49be59bf3d]eligibility for clinicaltrials:NCT00114179 [clinicaltrials_resource:fe9f488391586c4de94cd47b97f0ad1b]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
INR ≤ 1.5 [clinicaltrials_resource:05d1f10afcca0d28c020fe3868402160]
Bio2RDF identifier
05d1f10afcca0d28c020fe3868402160
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:05d1f10afcca0d28c020fe3868402160
identifier
clinicaltrials_resource:05d1f10afcca0d28c020fe3868402160
title
INR ≤ 1.5
@en
type
label
INR ≤ 1.5 [clinicaltrials_resource:05d1f10afcca0d28c020fe3868402160]
@en